High energy production in mitochondria is essential for maintaining cardiac contraction in the heart. Genes regulating mitochondrial function are commonly downregulated during heart failure. Here we show that both PPARa and Sirt1 are upregulated by pressure overload in the heart. Haploinsufficiency of either PPARa or Sirt1 attenuated pressure overload-induced cardiac hypertrophy and failure, whereas simultaneous upregulation of PPARa and Sirt1 exacerbated the cardiac dysfunction. PPARa and Sirt1 coordinately suppressed genes involved in mitochondrial function that are regulated by estrogen-related receptors (ERRs). PPARa bound and recruited Sirt1 to the ERR response element (ERRE), thereby suppressing ERR target genes in an RXR-independent manner. Downregulation of ERR target genes was also observed during fasting, and this appeared to be an adaptive response of the heart. These results suggest that suppression of the ERR transcriptional pathway by PPARa/Sirt1, a physiological fasting response, is involved in the progression of heart failure by promoting mitochondrial dysfunction.
INTRODUCTION
Heart failure is a leading cause of death worldwide. The heart is an organ with high energy production and consumption because it must constantly pump blood against blood pressure. Cardiac myocytes harbor a high volume of mitochondria, which play a major role in mediating energy production in these cells. Cardiac hypertrophy is induced by increased mechanical load such as high blood pressure. Hypertrophic growth is initially a compensatory response that helps maintain cardiac function by reducing wall stress, but it eventually leads to the development of heart failure. This progression is well demonstrated by an experimental model, in which high blood pressure is induced in the heart, termed transverse aortic constriction (TAC). The left ventricle (LV) is subjected to high blood pressure by constriction of the aorta, which provokes cardiac hypertrophy and then heart failure. Heart failure represents a complex phenotype that includes reduced myocardial contractility, increased myocyte cell death, and myocardial fibrosis. During heart failure, mitochondria display ultrastructural and bioenergetic defects, which lead to insufficient energy production, increased oxidative stress, and cell death (Russell et al., 2005) . However, the mechanism mediating these pathological changes in mitochondria during the development of cardiac disease is not fully understood.
Nuclear receptors form a superfamily of transcription factors that orchestrate a wide range of biological functions, including development, immune responses, cell growth, and metabolism (Glass, 2006) . DNA-binding sites of nuclear receptors, known as hormone response elements (HREs), consist of a common hexad sequence, such as AGGTCA or AGAACA, which can be configured into direct repeats, inverted repeats, and everted repeats (Mangelsdorf et al., 1995) . In addition, the single hexad sequence is recognized by several nuclear receptors, including estrogen related receptors (ERRs) (Sladek et al., 1997) .
ERRs consist of three different isoforms: ERR-a, -b, and -g. ERRs are activated by transcription coactivators such as PGC1a and PGC-1b, crucial regulators of mitochondrial function (Huss et al., 2002) . The ERR response elements (ERREs), whose consensus sequence is TNAAGGTCA (where N is any nucleotide), are frequently found in the promoter regions of genes regulating mitochondrial function, such as those encoding components of the respiratory chain (Giguè re, 2008) . In addition, ERRs directly regulate transcription of modulators of cardiac contraction, namely Atp2a2 and Hrc, and important transcription factors, including ERRa itself, PGC-1a, Jarid2, and Irx4, and, therefore, ERRs are recognized as pleiotropic regulators of heart function Wang et al., 2005) . Gene disruption of mouse ERRa causes heart failure with impaired mitochondrial ATP production under pressure overload conditions . Since downregulation of the PGC1a-ERRa axis and consequent development of both mitochondrial and contractile dysfunction are frequently observed in heart failure patients (Karamanlidis et al., 2010; Sihag et al., 2009) , impaired ERR target gene expression is considered to be a hallmark of failing hearts.
Peroxisome proliferator-activated receptors (PPARs), comprising PPARa, -b/d, and -g, belong to the nuclear receptor superfamily. PPARs form heterodimers with Retinoid X receptors (RXRs) and bind to a response element called direct repeat 1 (DR1) or PPAR response element (PPRE), whose consensus sequence is AGGTCANAGGTCA (Schoonjans et al., 1996) , with PPAR and RXR occupying the 5 0 and 3 0 AGGTCA sequences, respectively. PPARa is activated by fatty acid ligands to induce expression of genes promoting fatty acid uptake and oxidation, whereas PPARg is an important regulator of adipogenesis and fat storage (Spiegelman, 1998) . In the heart, artificial ligands for PPARa, such as fenofibrate, protect against endothelin-induced cardiac hypertrophy and failure (Irukayama-Tomobe et al., 2004) , and cardiac function is severely damaged in PPARa null mice during pressure overload (Smeets et al., 2008) . Cardiac-specific overexpression of PPARa also results in hypertrophy and failure in association with intracellular accumulation of neutral lipids, termed lipotoxicity (Finck et al., 2002) . Thus, PPARa both positively and negatively regulates cardiac function. The molecular mechanism through which PPARa exerts dichotomic effects on the heart remains to be elucidated.
Silent information regulator 1 (Sirt1) plays an important role in gene silencing and life span extension under starvation conditions (Bordone and Guarente, 2005) . Cellular responses to nutrient starvation, including metabolic adaptation to fasting, are mediated by Sirt1 through its protein-protein interaction with and posttranslational modification of PGC-1a and PPAR (Rodgers et al., 2008) . However, Sirt1-mediated regulation of PPAR is complex. For example, fatty acid mobilization from adipose tissues is enhanced by Sirt1 through inhibition of PPARg (Picard et al., 2004) , whereas Sirt1 activates PPARa to promote fatty acid oxidation in the liver (Purushotham et al., 2009 ).
We here demonstrate that PPARa negatively regulates expression of genes involved in mitochondrial respiration and cardiac contraction through direct interaction with a single hexad motif of HREs, such as ERRE, in the heart under pressure overload. The negative regulation of a single hexad motif of HREs by PPARa takes place independently of RXR but in a Sirt1-dependent manner in the heart in response to pressure overload, as well as under physiological fasting conditions. These results suggest that binding of PPARa/Sirt1 to the single hexad motif of HREs plays an important role in mediating downregulation of the ERR target genes, which in turn promotes heart failure. Although this mechanism could mediate physiological adaptation of the heart in response to starvation, inappropriate activation of the same mechanism could lead to impaired energy production and contractility, thereby facilitating progression of heart failure during pressure overload, when the heart requires high energy to maintain contraction against an elevated afterload.
RESULTS

PPARa and Sirt1 Mediate Pressure Overload-Induced Cardiac Hypertrophy
The level of Sirt1 in the nuclear fraction of the heart was upregulated in response to pressure overload imposed by transverse aortic constriction (TAC), consistent with our previous report (Alcendor et al., 2007) . TAC also upregulated PPARa ( Figure 1A ) with activation of luciferase reporter gene driven by three repeats of the PPAR response element in vivo (Tg-PPRE-luc) (Figure S1A ). PPARa interacts with Sirt1 in cardiac myocytes (Figure 1B) . Haploinsufficiency of either PPARa (PPARa +/À ) or Sirt1 (Sirt1 +/À ) attenuated cardiac hypertrophy after 4 weeks, but not 2 weeks, of TAC, as characterized by heart weight/body weight ( Figure 1C ), heart weight/tibia length (Figures S1B and S1C), and myocyte size ( Figure 1D ). Echocardiographic analyses showed that TAC-induced systolic dysfunction, characterized by a decreased ejection fraction, was prevented in PPARa +/À and Sirt1 +/À mice ( Figure 1E ). Thus, PPARa and Sirt1 play an important role in mediating TAC-induced cardiac hypertrophy and failure. Transgenic mice with cardiac-specific PPARa overexpression (Tg-PPARa) show moderate cardiomyopathy characterized by hypertrophy and systolic dysfunction. However, the PPARa-induced cardiac hypertrophy was ameliorated by downregulation of Sirt1 (Tg-PPARa/Sirt1 +/À ) ( Figures 1F and S1D ), suggesting that endogenous Sirt1 is required for the cardiac hypertrophy observed in the Tg-PPARa. Taken together, these results indicate that PPARa and Sirt1, in concert, facilitate pressure overload-induced cardiac dysfunction and hypertrophy. Since both PPARa and Sirt1 were upregulated in the heart under pressure overload conditions, in order to test whether simultaneous upregulation of PPARa and Sirt1 is sufficient for mediating cardiac hypertrophy, we crossed two lines each of Tg-Sirt1 and Tg-PPARa to generate bigenic mice overexpressing both PPARa and Sirt1 ( Figure S1E ). The PPARa transgene was FLAG-tagged (Finck et al., 2002) and bound to both endogenous and exogenous Sirt1 in the heart ( Figure S1F ). We did not detect any acetylation of PPARa even in Tg-PPARa with a Sirt1 À/À background ( Figure S1G ). As shown previously, mild cardiac hypertrophy was observed in Tg-PPARa. However, cardiac hypertrophy was more severe in the Tg-PPARa/Tg-Sirt1 bigenic mice ( Figures 1G, 1H , and S1H). Lung congestion was more prominent in the Tg-PPARa/Tg-Sirt1 bigenic mice ( Figure S1I ). Systolic function was impaired in the Tg-PPARa/Tg-Sirt1 bigenic mice, as evidenced by a decreased ejection fraction and fractional shortening ( Figure 1I and Table S1 ). These results suggest that co-upregulation of Sirt1 and PPARa is sufficient to induce cardiac hypertrophy and failure, even without pressure overload.
Sirt1
Attenuates PPARa-Induced Lipotoxicity Sirt1 has been reported to activate PPARa (Purushotham et al., 2009) . The cardiomyopathic phenotype in the Tg-PPARa/ Tg-Sirt1 bigenic mice could be due to enhancement of PPARamediated transcriptional activation by Sirt1. To test this hypothesis, expression levels of PPARa target genes were evaluated. As expected, known target genes of PPARa, such as Acox1, CptIb, Cd36, and Pdk4, were upregulated in Tg-PPARa. However, expression of those genes was not significantly changed in the Tg-PPARa/Tg-Sirt1 bigenic mice compared to in Tg-PPARa (Figure 2A) . To elucidate the effect of Sirt1 on PPARa-induced PPRE activation in vivo, the Tg-PPRE-luc mice were crossed with Tg-PPARa and Tg-Sirt1. As shown in Figure 2B , PPARa-induced activation of the PPRE-luc activity was not significantly altered in the Tg-PPARa/Tg-Sirt1 bigenic mice. Furthermore, Sirt1 overexpression did not affect PPRE-luc activity induced by fasting, a physiological stimulus of PPARa. Thus, overexpression of Sirt1 does not affect PPARa-induced PPRE activation in the heart. Microarray analyses demonstrated that a subset of the PPAR target genes was upregulated, while the rest of the target genes were either downregulated or unaffected in the bigenic mice ( Figure 2C) . Thus, the effect of Sirt1 on PPARa-induced target gene expression was nonuniform in terms of directionality, rather than exhibiting simple enhancement, a result which does not support the involvement of PPRE-regulated genes in the cardiomyopathic phenotype observed in the Tg-PPARa/Tg-Sirt1 bigenic mice. 
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Although accumulation of neutral lipids, termed lipotoxicity, is thought to be a major cause of PPARa-induced cardiomyopathy (Finck et al., 2002) , PPARa-induced triglyceride accumulation was actually suppressed by Sirt1 ( Figures 2D and 2E) . Lipotoxicity is frequently accompanied by increased oxidative stress. PPARa-induced increases in H 2 O 2 were significantly attenuated in the presence of Sirt1 ( Figure 2F ). Thus, Sirt1-induced exacerbation of PPARa-induced cardiomyopathy in the Tg-PPARa/Tg-Sirt1 bigenic mice is not due to the enhancement of lipotoxicity.
The Target Genes of the Estrogen-Related Receptor (ERR) Are Downregulated in Tg-Sirt1/Tg-PPARa Bigenic Mice Despite the varied effects of Sirt1 on expression of PPARa target genes, surprisingly, microarray analyses revealed that PPARa and Sirt1 cooperatively downregulated expression of many, if not all, known and predicted target genes of ERRs ( Figure 3A) . Although a subset of the known ERR target genes, such as Mttp and Acox1, was not suppressed but rather upregulated, those genes are also known to be direct targets of PPARa. Furthermore, genes reported to be upregulated in ERRa knockout mice, such as myosin light chains , were upregulated in Tg-PPARa/Tg-Sirt1 bigenic mice, indicating that the bigenic mice have impaired ERR function. The expression level of representative ERR target genes regulating mitochondrial energy metabolism (Figure 3B) , cardiac contraction ( Figure 3C ), and transcription ( Figure 3D ) was further assessed by quantitative PCR. Overall, these ERR target genes were downregulated in Tg-PPARa and in Tg-Sirt1, and they were further downregulated in the Tg-PPARa/Tg-Sirt1 bigenic mice. These results suggest that expression of ERR target genes was coordinately downregulated by PPARa and Sirt1 in the heart. We also examined the expression levels of ERRs and PGC-1s, since ERRa and PGC-1a are reported to be ERR target genes Wang et al., 2005) . These genes were downregulated in Tg-PPARa/ Tg-Sirt1 bigenic mice, except for ERRg ( Figure 3E ).
Mitochondria in the hearts of the Tg-PPARa/Tg-Sirt1 bigenic mice exhibited structural abnormalities, such as reduced cristae density ( Figures 4A and 4B ), but normal mitochondrial volume ( Figure 4C ). In addition, ATP production was impaired in mitochondria isolated from the Tg-PPARa/Tg-Sirt1 bigenic mice ( Figure 4D ). Notably, downregulation of ERR target genes regulating myocardial contraction coincided with systolic dysfunction in Tg-PPARa/Tg-Sirt1 bigenic mice ( Figure 1I ). Taken together, these results suggest that downregulation of the ERR target genes is well correlated with the functional defects in both mitochondria and contractility in the TgPPARa/Tg-Sirt1 bigenic mice.
PPARa and Sirt1 Suppress ERRE-Mediated Gene Expression
Since the ERRE contains a whole binding sequence of PPARa as a monomeric unit (AGGTCA) ( Figure 5A ), we hypothesized that PPARa suppresses gene expression through direct interaction with the ERRE. To investigate whether PPARa binds to the ERRE, double-stranded DNA pull-down assays were performed with biotin-labeled double-stranded DNA ( Figure 5B ) and bacterially expressed recombinant PPARa. As shown in Figure 5C and Figure S2A , PPARa was pulled down with biotin-labeled double-stranded DNA comprising a PPRE, three repeats of ERRE with a 4 bp spacer (33ERRE) or a single ERRE (13ERRE), but not with that comprising a 33ERRE mutant (03ERRE). The interaction between PPARa and biotin-labeled 13 and 33ERRE was competitively inhibited by biotin-free double-stranded DNA containing ERRE(s), but not by that with the ERRE mutant(s), suggesting that PPARa directly binds to the ERRE in a sequence-specific manner. In heart lysates prepared from Tg-PPARa, PPARa was pulled down with biotin-labeled 13 and 33ERRE. The interaction between PPARa and 33ERRE was competitively inhibited by biotin-free 13ERRE ( Figures 5D and S2B ). Thus, PPARa is able to bind to a single hexad motif within the ERRE. As shown in Figure 5E and Figure S2C, Sirt1 was pulled down with an oligonucleotide containing a PPRE, as well as with one containing ERREs, more effectively from TgPPARa heart lysates than from nontransgenic heart lysates, suggesting that PPARa recruits Sirt1 to both the PPRE and the ERRE. The amount of RXR pulled down with the ERRE was less than that with the PPRE, suggesting that PPARa and RXR form a dimer more effectively on the PPRE than on the ERRE. ERRa was pulled down with a biotin-labeled ERRE, but the interaction was competitively inhibited in the presence of PPARa, indicating that PPARa and ERRa compete for the common DNA-binding site ( Figure 5E ). Endogenous PPARa was recovered with biotin-labeled 33ERRE more effectively from the heart lysate prepared after 4 weeks of TAC than from the control heart lysate ( Figures  5F and S2D ). Recombinant PPARa bound to ERREs even in the presence of 20-and 60-fold excesses of nonbiotin labeled polydeoxy (Inosinate-Cytidylate) acid as a nonspecific competitor (Figure S2E ). To examine whether PPARa binds to the AGGTCA motif in vivo, chromatin immunoprecipitation (ChIP) assays were performed. As expected, genomic flanking regions of the PPRE, such as those in the promoter regions of Acox1 and PGC-1a (À2168 to À2044), were significantly precipitated with anti-FLAG antibody when FLAG-tagged PPARa was expressed in the hearts of Tg-PPARa and Tg-PPARa/Tg-Sirt1 bigenic mice ( Figure 5G ). FLAG-tagged PPARa also bound to flanking regions of single AGGTCA motifs, which are not configured as a typical PPRE but are found either within an ERRE or as an isolated AGGTCA motif, such as those in the promoter regions of Sdha, PGC-1a (À3348 to À3249), and Atp2a2 ( Figure 5G ). Increased expression of PPARa resulted in increased DNA binding of both PPARa and Sirt1 on flanking regions of the single hexad motif in the promoter regions of PPARa/Sirt1 suppressed genes ( Figure 5H ). There was no typical PPRE located within the 1 kb flanking region of all promoters we tested by ChIP assays, except in those of Acox1 and PGC1a ( Figure 5G ), suggesting that PPARa recruits Sirt1 to the single hexad motif in the heart. The downregulation of the ERR target genes observed in Tg-PPARa was partially normalized by haploinsufficiency of Sirt1 ( Figure 5I ). Thus, Sirt1 recruited by PPARa negatively regulates gene expression directed by the single hexad motif.
PPARa Suppresses the ERRE in a Sirt1-Dependent and RXR-Independent Manner
To investigate whether PPARa and Sirt1 suppress promoter activity through interaction with the ERRE, reporter gene assays were performed in cultured myocytes. As shown in Figure 6A , PPARa and Sirt1 cooperatively suppressed reporter activity driven by the promoter region of Ndufv1 containing three hexad motifs. The À3.5 kb to À0.35 kb promoter region of PGC1a also contains multiple common hexad motifs. PPARa and Sirt1 cooperatively suppressed reporter activity driven by a 3.5 kb, but not by a 0.35 kb, promoter region. The PGC-1a promoter contains a typical PPRE. PPARa may displace the other PPARs, preventing them from binding to the PPRE and thereby suppressing the promoter activity. However, PPARa and Sirt1 cooperatively suppressed reporter gene activity driven by the PGC-1a promoter with a PPRE mutation. Thus, the PPRE is not required for PPARa/Sirt1-mediated suppression of PGC-1a promoter activity. PPARa and Sirt1 also suppressed reporter activity driven by three repeats of the ERRE connected to the thymidine kinase promoter, whereas VP16-ERRa, a transcriptional activation domain fused to ERRa, normalized both the reporter gene activity and ERR target gene expression, which were suppressed by PPARa/Sirt1 in cultured myocytes (Figures 6B and S3A) . However, coexpression of PPARa and Sirt1 did not effectively suppress, and VP16-ERRa failed to activate, the reporter activity when the ERRE sequences were mutated ( Figure 6B ). Thus, the single hexad motif of HREs, including that in the ERRE, plays an essential role in mediating transcriptional suppression by PPARa and Sirt1. PPARamediated suppression of ERRE-reporter activity was attenuated by knockdown of Sirt1 (Figure 6C) , suggesting that endogenous Sirt1 is a crucial partner for the PPARa-mediated suppression of the ERRE.
PPARa-induced PPRE activation may contribute to the suppression of the ERRE through recruitment of transcription activation machinery from the ERRE to the PPRE, termed squelching. To test this possibility, we examined the effect of a PPARa mutant (PPARaDAF2), which cannot bind to the coactivators, on ERRE-reporter gene activity. The PPARa mutant retained the ability to bind to Sirt1 and suppressed ERRE reporter gene activity in the presence of Sirt1 ( Figure 6D ). Thus, PPARa-mediated squelching is not required for the ERRE suppression.
Since PGC-1a and PGC-1b activate ERRs, downregulation of PGC-1s ( Figure 3E ) may be a major mechanism for PPARa/ Sirt1-induced downregulation of ERR target genes. However, suppression of ERRE, Ndufv1, and PGC-1a reporter genes by PPARa/Sirt1 was observed even in the presence of PGC-1a overexpression ( Figures 6E and S3B) . Furthermore, overexpression of PGC-1a failed to normalize ERR target gene suppression by PPARa/Sirt1 ( Figure S3C ). Thus, downregulation of PGC1a is not essential for PPARa/Sirt1-mediated ERRE suppression.
RXRs play an important role in mediating DNA binding and transcriptional activation of PPARa through the PPRE. However, an isolated single hexad motif, such as that in the ERRE, would not provide a binding site for RXR. Therefore, we investigated the role of RXR in mediating the function of PPARa and Sirt1 at the ERRE. To examine the role of RXR in the interaction between PPARa and Sirt1, immunodeprivation of RXRs was performed with an anti-RXR antibody recognizing all RXR isoforms. Sirt1 was coprecipitated with FLAG-PPARa after
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PPARa/Sirt1 Suppresses ERR Transcriptional Pathway immunodeprivation of RXR, suggesting that RXR is not required for interaction between PPARa and Sirt1 in the heart ( Figure 6F ). To assess the role of RXR in PPARa/Sirt1-mediated ERRE suppression, we examined the effects of RXRa and an RXRa mutant lacking the N-terminal DNA-binding domain, RXRa(DN), on ERRE reporter activity. Although PPARa-induced PPRE activation was significantly suppressed by RXRa(DN), PPARa/ Sirt1-mediated ERRE suppression was not affected ( Figure 6G ). Furthermore, although RXRa significantly enhanced PPRE reporter activity in the presence of PPARa, it did not affect PPARa/Sirt1-mediated ERRE suppression ( Figure 6H ). These results suggest that RXR is a crucial factor for PPARa-induced PPRE activation, but not for PPARa/Sirt1-mediated ERRE suppression ( Figure 6M, left) .
Since PPRE/DR1 contains the single hexad motif (Figure 5A ), the PPARa/Sirt1 complex may suppress transcription under circumstances where the level of RXRs is insufficient on the PPRE/DR1. To test this hypothesis, we introduced different doses of the PPRE reporter genes, together with PPARa and Sirt1, into myocytes. PPARa-induced luminescence increased sharply in response to increased amounts of the PPRE reporter gene in the low dosage range, but became saturated in the high dosage range. The saturated reporter activity was augmented, however, by overexpression of RXRa, suggesting that the amount of endogenous RXRs forming dimers with exogenous PPARa on the PPRE is limited ( Figure 6I ). PPARa-induced PPRE activation was not significantly changed by overexpression of Sirt1 when a smaller amount of PPRE reporter plasmid was introduced, but Sirt1 suppressed the reporter activity when a higher amount of PPRE reporter was cotransfected into the cells ( Figure 6J ). The PPARa-induced PPRE reporter activation was enhanced by knocking down Sirt1 ( Figure 6K ), suggesting that activation of the PPRE reporter gene by PPARa may be determined by the balance between PPARa/RXRmediated transcriptional activation and PPARa/Sirt1-mediated transcriptional suppression when a high level of PPRE reporter is used. PPARa/Sirt1-mediated PPRE suppression was reversed by overexpression of RXRa ( Figure 6L ). These results suggest that PPARa/Sirt1 suppresses transcription at the PPRE when RXRs are insufficient to cover the other side of the half-core site of PPRE ( Figure 6M, right) . Thus, PPARa facilitates both activation of the PPRE and suppression of the single hexad motif, as in the ERRE, with RXR and Sirt1, respectively.
PPARa and Sirt1 Suppress ERR Target Gene Expression during Pressure Overload in the Heart
To examine whether PPARa and Sirt1-mediated gene suppression takes place in the heart subjected to pressure overload, ChIP assays were performed. Binding of PPARa and Sirt1 to the flanking region of the single hexad motif was significantly increased after TAC in the promoters of Shda, PGC-1a, and Apt2a2 after 2 weeks ( Figure S4A ) and 4 weeks of TAC (Figure 7A) . The level of histone H3 acetylation at lysine 9, which is deacetylated by Sirt1, was decreased in the promoter regions of the ERR target genes after TAC. The occupancy of ERRa on the ERREs was decreased by pressure overload ( Figure 7B ) and by overexpression of PPARa ( Figure S4B ). On the other hand, knocking down ERRa did not affect ERRE reporter gene activity or recruitment of PPARa to the ERRE in cultured cardiac myocytes ( Figures S4C-S4E ), despite the fact that the occupancy of ERRa on the flanking region of ERREs was significantly reduced ( Figure S4F ) and that expression of several ERR target genes was significantly attenuated by downregulation of ERRa ( Figure S4G ). Thus, downregulation of ERRa is not sufficient to induce PPARa/Sirt1-mediated ERRE suppression. TAC-induced downregulation of the ERR target genes was attenuated in PPARa +/À and Sirt1 +/À mice ( Figures 7C and  S4H) . Thus, endogenous PPARa and Sirt1 are both involved in the suppression of the ERR target genes in the heart during pressure overload.
PPARa/Sirt1-Induced Suppression of ERR Target Gene Expression Is Adaptive during Fasting
In the last part of the study, a physiological role for the gene suppression through PPARa and Sirt1 interaction was investigated. Since both PPARa and Sirt1 are crucial factors that mediate fasting responses, we hypothesized that PPARa/Sirt1-mediated ERR suppression is a fasting response. To test this hypothesis, PPARa +/À and Sirt1 +/À mice were subjected to fasting for 24 hr. As shown in Figure 7D , although typical PPAR target genes, including Cd36 and Fabp4, were upregulated following fasting in wild-type mice, their expression was reduced in PPARa +/À mice. ERR target genes, such as Sdha, Atp2a2, and PGC1a were downregulated in wild-type mice following fasting, but this downregulation was partly prevented in PPARa +/À mice, suggesting that PPARa mediates both PPRE activation and ERRE suppression during fasting. The fasting-induced downregulation of ERR target genes was partly normalized in Sirt1 +/À mice. Thus, Sirt1 is required for suppression of ERR target genes during starvation in the heart. Increased NAD + and decreased NADH levels were observed in the heart following both fasting and TAC, conditions known to effectively promote Sirt1 activation due to an increased NAD/NADH ratio ( Figure 7E ). To investigate the role of PPARa and Sirt1 in the heart under fasting, cardiac function was assessed. Cardiac systolic function, such as ejection fraction, was slightly decreased in wildtype mice after fasting, but not in either PPARa +/À or Sirt1 +/À mice ( Figure 7F ). Using an isolated working mouse heart model, under nutrient-free conditions, spontaneous beating terminated earlier in hearts isolated from PPARa +/À and Sirt1 +/À mice than in hearts from wild-type mice, suggesting that PPARa and Sirt1 play an important role in maintaining beating of the heart under starvation conditions ( Figure 7G ). After 72 hr of incubation with a glucose-free medium, the survival rate was decreased in control cultured myocytes, but was improved by exogenous PPARa. This protective effect was attenuated by knockdown of Sirt1, suggesting that Sirt1 is required for the PPARa-mediated prolongation of myocyte survival under starvation conditions ( Figure 7H ). These results suggest that ERRE suppression by the PPARa/Sirt1 is a fasting response to prolong cardiac working time and cell survival under starvation conditions through reduction of mitochondrial and systolic outputs. This is in contrast to the condition of pressure overload, where the heart cannot afford to slow down because of the need to maintain cardiac output against increased afterload. Thus, ERRE suppression by the PPARa/Sirt1 complex is induced by both pressure overload and fasting, but the advantageousness of its function is context-dependent. (G) Hearts were isolated from PPARa +/À and Sirt1 +/À mice and subjected to the Langendorff perfused heart experiment without any nutrients in the perfusate. The duration of consecutive beating was evaluated in each heart (N = 7-9). (H) PPARa and Sirt1 prolong survival of cultured cardiac myocytes under glucose-free conditions. The indicated expression or knockdown was introduced with adenovirus vectors. Cell viability was evaluated with trypan blue dye exclusion following incubation with complete or glucosefree medium for 72 hr (N = 3). Error bars represent SEM.
(I) Schematic representations of the regulatory roles of PPARa, Sirt1, and RXR on the PPRE and the ERRE during pressure overload and fasting. PPARa shifts the energy source to fatty acids through PPRE activation and minimizes nutritional usage through ERRE suppression, with the functional binding partners RXR and Sirt1, respectively. PPARa-mediated ERRE suppression is triggered by pressure overload, which exacerbates cardiac dysfunction due to insufficient energy production.
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PPARa/Sirt1 Suppresses ERR Transcriptional Pathway binding element of PPARa. Furthermore, DNA-binding sequences directly bound by PPARa are found not only in the promoters of 16% of upregulated genes, but also in the promoters of 18% of downregulated genes in the presence of a PPARa ligand (van der Meer et al., 2010) . These findings support the possibility that PPARa could negatively regulate transcription through the single hexad motif. Our results not only establish the functional significance of the regulation of the single hexad DNA-binding motif by PPARa, but also show that it could contribute to mitochondrial dysfunction and eventual development of heart failure under conditions of mechanical loading in the heart.
Dichotomous Functions of PPARa in the Heart
The cardiac role of PPARa is controversial because both PPARa knockout and PPARa overexpression lead to detrimental phenotypes in the mouse heart (Finck et al., 2002; Smeets et al., 2008) . The detrimental effect seen in PPARa homozygous knockout mice may result from impaired PPRE-mediated gene expression. Our results suggest that PPARa-mediated ERRE suppression is detrimental to the heart. Since the PPARa/RXR dimer exhibits a higher affinity for the PPRE than for the single hexad motif (data not shown), PPRE activation is probably the primary role of the PPARa/RXR dimer. However, when PPARa (and Sirt1) is upregulated, the PPARa-Sirt1 complex suppresses ERRE independently of RXR. Although PPARa-mediated activation of the PPRE is protective, suppression of ERRE could be detrimental under stress conditions, such as pressure overload. Thus, our results provide a potential explanation for the controversy regarding the cardiac role of PPARa.
Cardiac Role of Sirt1
Sirt1 is required for PPARa-induced regulation of target gene expression through the PPRE in the liver (Purushotham et al., 2009 ), whereas we here show that PPARa and Sirt1 work together, but that they suppress the ERRE in the heart. The direction of the transcriptional activity of the PPARa/Sirt1 complex may depend upon DNA-binding sites, requirement of RXR, cell type, or possibly other unknown mechanisms.
Sirt1 deacetylates ERRa to enhance its DNA-binding in 293 cells (Wilson et al., 2010) . Although ERRa was modestly acetylated in the Sirt1 À/À heart, ERRa acetylation was below the detection limit in wild-type mice both at baseline and after pressure overload ( Figure S4I ). Even if Sirt1 deacetylates ERRa in the heart under pressure overload, its role in mediating the PPARa/Sirt1-induced suppression of ERRE remains to be elucidated. Since suppression of the ERR target genes under pressure overload conditions is attenuated in Sirt1 +/À mice ( Figure 7C ), upregulation of endogenous Sirt1 plays an essential role in mediating suppression of the ERRE. The results of the ChIP experiments showed that the acetylation status of histone H3 at lysine 9, a specific deacetylation site of Sirt1, located in flanking regions of the ERRE, was decreased during pressure overload ( Figure 7A ). Thus, we speculate that upregulation and recruitment of Sirt1 through PPARa may inhibit transcription through the ERRE via histone deacetylation. Alternatively, Sirt1-mediated recruitment of nuclear corepressors (Picard et al., 2004) or histone H1 (Vaquero et al., 2004 ) may contribute to the suppression of ERRE-mediated transcription. Further investigation is required to elucidate the mechanism by which the PPARa/Sirt1 complex mediates the suppression.
Potential Effects of PGC1s, ERRs, and the Other Nuclear Receptors on the ERRE in the Failing Heart Although PGC-1s are important transcription cofactors for ERRs, downregulation of PGC-1a was not essential for PPARa/Sirt1-mediated ERRE suppression ( Figures 6E, S3B and S3C). Knockdown of ERRa does not appear to be sufficient for inducing recruitment of PPARa to ERREs, whereas upregulated PPARa was recruited to the ERRE ( Figure S4C ). The level of PPARa at baseline may not be sufficient to occupy ERREs in neonatal myocytes. Alternatively, ERRg or ERRb may effectively compensate for the downregulation of ERRa, thereby preventing the recruitment of PPARa to ERREs. Interestingly, each monomeric unit of the nuclear receptor commonly recognizes and binds to the single hexad motif, regardless of the overall receptor assembly (McKenna et al., 2009) . Therefore, our finding that PPARa can bind to the single hexad motif is potentially applicable to the other nuclear receptors as well. In addition, it is possible that the PPARa/Sirt1complex suppresses targets of other nuclear receptors when their DNA-binding sites do not have a typical PPRE, but are more similar to an isolated single hexad-like sequence. More investigations are needed in order to elucidate the role of the PPARa/Sirt1complex in each nuclear receptor element.
Fasting Responses Involved in the Development of Cardiomyopathy
Fatty acid catabolism plays a crucial role in maintaining energy homeostasis during fasting, because fat stored under fed conditions becomes a major source of energy during fasting. Plasma fatty acids are transported into mitochondria and then converted to acetyl-CoA through b-oxidation. The acetyl-CoA is consumed by the tricarboxylic acid (TCA) cycle, which couples to ATP synthesis through the electron transport chain. Interestingly, PPARa target genes harboring a PPRE in their promoter regions are mainly found in the upstream metabolic pathway, including those involved in fatty acid transport and b-oxidation (Rakhshandehroo et al., 2007) . In contrast, ERR target genes are relatively enriched in the downstream metabolic pathway, including the TCA cycle and the electron transport chain. Here, we showed that fasting-induced ERR target gene suppression is attenuated in PPARa +/À and Sirt1 +/À mice ( Figure 7D ). Thus, although
PPARa facilitates fatty acid utilization through PPRE activation in the presence of RXR, together with Sirt1, PPARa can minimize nutritional consumption through ERRE suppression under starvation conditions ( Figure 7I ). Since the mitochondrion is the major energy-generating organelle coupling with nutritional consumption, and the heart is a major organ consuming energy and nutrition, the PPARa/Sirt1-mediated restriction of the mitochondrial energy metabolism could contribute to survival of cells and organisms by minimizing the consumption of body-stored nutrition during starvation. Reduced metabolic rate is believed to increase survival time in hibernating animals (Staples and Brown, 2008) . Starvation leads to decreased cardiac work, such as reduced fractional shortening in animals. We found that the fasting-induced reduction of ejection fraction was abolished in PPARa +/À and Sirt1 +/À mice ( Figure 7F ). Thus, the cardiac fasting response, which slows down cardiac outputs, is mediated by PPARa and Sirt1. Our data suggest that PPARa/Sirt1-mediated ERRE suppression contributes to the delay of cell death as well as termination of cardiac function during starvation conditions. The physiological significance of this mechanism should be further investigated in the heart in vivo.
Our data support the notion that both PPARa and Sirt1 are crucial mediators of the fasting response. Importantly, although such a metabolic adaptation, which minimizes consumption of nutrition, may provide a survival advantage during fasting, it could be inappropriate during pressure overload, when the heart requires energy to maintain contraction against increased mechanical load. It is currently unknown how PPARa and Sirt1 are upregulated in the failing heart. Reduced nutrition and/or ATP resulting from high energy expenditure may be sensed as conditions of reduced nutritional intake in the heart subjected to pressure overload. Indeed, decreased ATP and creatine phosphate have been observed in human heart failure patients (Weiss et al., 2005) . In summary, PPARa/Sirt1-mediated downregulation of genes regulated by the single hexad unit, including a subset of ERR target genes, induces mitochondrial dysfunction, which plays an important role in mediating heart failure. We propose that normalizing the level of PPARa and Sirt1 to attenuate ERRE suppression and to achieve physiological activation of the PPRE by PPARa/RXR may alleviate the mitochondrial dysfunction commonly observed in heart failure patients with increasing mechanical loading.
EXPERIMENTAL PROCEDURES
Transgenic Mice
The following transgenic mice were used for this study: Cardiac-specific overexpression of PPARa (Tg-PPARa) or Sirt1 (Tg-Sirt1), Tg-PPARa/Tg-Sirt1, cardiac-specific Sirt1 heterozygous knockout (Sirt1 +/À ), Tg-PPARa/Sirt1 +/À , PPRE-luciferase transgenic (Tg-PPRE-luc), Tg-PPARa/Tg-PPRE-luc, TgSirt1/Tg-PPRE-luc, Tg-PPARa/Tg-Sirt1/Tg-PPRE-luc, and PPARa heterozygous knockout (PPARa +/À ) mice. The generation strategies and genetic backgrounds of these transgenic mice are described in the Supplemental Information. All procedures involving animals were performed in accordance with protocols approved by the University of Medicine and Dentistry of New Jersey.
Transverse Aortic Banding
Mice were anesthetized with pentobarbital sodium. The left chest was opened. Aortic constriction was performed by ligation of the transverse artery and left common carotid artery with a 26-or 27-gauge needle.
Isolated Working Mouse Heart Model
Mouse hearts were dissected and perfused with a perfusate [120 mM NaCl, 25 mM NaHCO 3 , 5.9 mM KCl, 1.2 mM MgCl 2 , 2.5 mM CaCl 2 , 0.5 mM EDTA]. The termination time of spontaneous beating was defined as the time at which +dP/dt of the isolated heart reached less than 400 mmHg/second, or the beating was paused for more than 0.6 s, whichever came first.
Echocardiography
Mice were anesthetized using avertin (Sigma), and echocardiography was performed to take two-dimension guided M-mode of left ventricular (LV) internal diameter. LV ejection fraction was calculated as [(LVEDD) 3 -(LVESD) 3 ]/ (LVEDD) 3 3 100. LVEDD; Left ventricular end-diastolic diameter; LVESD: LV end-systolic diameter.
Microarray Analyses
Total RNA from the hearts was extracted using the RNeasy Fibrous Tissue Mini Kit (QIAGEN). The RNA was used to produce a biotin-labeled cRNA probe for hybridization to a mouse expression array 430_A2.0 gene chip (Affymetrix, Santa Clara, CA). The expression signal for each probe-set was obtained by the RMA (robust multi-chip analysis) method, and the detection was assessed by the MAS (Microarray Suite) 5.0 method. Expression patterns of regulated genes were graphically represented in a heat map. The clustering and visualization was carried out by the MultiExperiment Viewer (MeV) (http://www.tm4. org/mev.html). PPAR and ERR target genes were selected from published articles. Those target genes overlapping genes whose expression was significantly changed in Tg-PPARa, Tg-Sirt1, and Tg-PPARa/Tg-Sirt1 bigenic mice were extracted to generate heat maps.
ATP Synthesis
Mitochondria were freshly isolated from the ventricle using a mitochondria isolation kit (Sigma, MITOISO1). The isolated mitochondria from 50 mg tissue weight was suspended with 50 ml storage buffer [10 mM HEPES pH 7.4, 250 mM Sucrose, 2 mM K 2 HPO 4 ], resulting in around 100 ml final volume of mitochondrial fraction. ATP production was measured by luminometric assay using an ATP bioluminescent assay kit (Sigma FL-AA). The ATP assay mix was diluted with the dilution buffer (1000-fold dilution). The diluted ATP assay mix (25 ml) was combined with 25 ml substrate buffer [5 mM HEPES pH 7.9, 210 mM Mannitol, 70 mM Sucrose, 10 mM Pyruvate, 10 mM Malate, 4 mM K 2 HPO 4 ], and then 1 ml mitochondrial solution was added. After 5 min incubation at room temperature, the reaction was started by the addition of 1 ml 12.5 mM ADP. The luminescence was measured by luminometer for 30 s. The mean value of non-Tg was expressed as 1.
Quantitative RT-PCR Total RNA was prepared from left ventricles using the RNeasy Fibrous Tissue Mini Kit (QIAGEN), and then cDNA was generated using M-MLV Reverse transcriptase (Promega). Real-time RT-PCR was performed using the Maxima SYBR Green qPCR master mix (Fermentas). Ribosomal RNA (15S) was used as an internal control. The oligonucleotide primers used to carry out the PCRs are described in the Supplemental Information.
Luciferase Assay
Luciferase activity was measured with a luciferase assay system (Promega). Dissected ventricles from Tg-PPRE-luc transgenic mice were weighed and lysed with 300 ml Reporter lysis buffer (Promega) per 50 mg tissue weight using a Polytron homogenizer. In cultured mycocytes, reporter and expression plasmids were transfected into neonatal primary myocytes (12-well plate) using LipofectAmine 2000 (Invitrogen). The amounts of expression vectors transfected into cells per well were 0.3 mg PPARa, 0.3 mg Myc-PPARa, 0.3 mg PPARaDAF2, 0.01 and 0.1 mg Sirt1, 0.1 and 0.3 mg RXRa, 0.6 mg RXRa(DN), 0.3 mg Myc-VP16-ERRa, and 0.3 mg luciferase reporter plasmids. The total amount of plasmid vectors was kept constant (1 to 1.3 mg) using the control vector. Alternatively, after overnight culture, adenovirus vectors carrying Sirt1 (0.1 to 3 moi), PPARa (5 moi), siRNA-Sirt1 (10 moi), siRNA-ERRa (10 moi) or siRNA-scramble (10 moi) were transduced. The total moi of adenovirus was kept constant using lacZ virus. Cells were lysed with 100 ml reporter lysis buffer after 1-4 days of transfection or transduction. For both tissue and cultured cell lysates, the luminescence was normalized by protein content.
Immunoblotting
Mouse heart tissue samples (10-30 mg) were analyzed by western blot using antibodies against PPARa (Cayman), Sirt1 (Millipore), RXR (Santa Cruz), ERRa (Millipore), histone H3 (Cell Signaling Technology), acetylated-lysine (Cell Signaling Technology), tubulin (Sigma), and GAPDH (Sigma).
Double-Stranded DNA Pull-Down Assay
Mouse heart tissue samples were weighed and lysed with 0.5 ml lysis buffer containing 10 mM Tris (pH 8), 3 mM CaCl 2 , 1% NP-40, 320 mM Sucrose, 0.1 mM EDTA, 1 mM DTT, and Protease Inhibitor Cocktail (Sigma) per 50 mg tissue weight. The heart lysate (50 ml) was diluted with an equal volume of 2 3 pull-down buffer (20 mM HEPES [pH 8], 100 mM KCl, 5 mM MgCl 2 , 2 mM EDTA, 2 mM DTT, and 0.2% NP-40. Biotin-labeled double-stranded DNA (total 15 pmol/100 ml) and 15 ml streptavidin-agarose (Pierce) were added to the lysate and rotated at 4 C for 2 hr. The streptavidin-agarose was washed with 1 ml 13 pull-down buffer three times. Biotin labeled sense and nonbiotinlabeled antisense oligonucleotides were purchased from IDT (Integrated DNA Technologies) and annealed using a thermal cycler to generate biotin labeled double-stranded DNA.
Chromatin Immunoprecipitation Assay
The ChIP assays were performed using the SimpleChIP Enzymatic Chromatin IP kit (Cell Signaling Technology #9002) with several modifications. Briefly, formaldehyde-crosslinked chromatin solution was prepared from ventricles corresponding to 200-1000 mg (from 3-10 mice). The chromatin solution (1-5 mg DNA) was used for each immunoprecipitation with 1 mg antibodies and 15 ml protein G-agarose beads. Collected chromatin fragments were measured by quantitative PCR with oligonucleotide primers described in the Supplemental Information.
Statistical Methods and Error Bars
Statistical comparisons were made using the Student's t test. p < 0.05 was defined as statistically significant and indicated by a filled asterisk. p > 0.05 was indicated by NS. All error bars represent SEM.
ACCESSION NUMBERS
GSE33101 is the accession number of the microarray data, which is available on the Gene Expression Omnibus website (http://www.ncbi.nlm.nih.gov/geo). 
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